featured
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial
JAMA 2023 Jun 27;329(24)2135-2144, HS Chen, Y Cui, ZH Zhou, H Zhang, LX Wang, WZ Wang, LY Shen, LY Guo, EQ Wang, RX Wang, J Han, YL Dong, J Li, YZ Lin, QC Yang, L Zhang, JY Li, J Wang, L Xia, GB Ma, J Lu, CH Jiang, SM Huang, LS Wan, XY Piao, Z Li, YS Li, KH Yang, DL Wang, TN NguyenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.